Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Raised to $35 at Leerink Partners

April 27, 2026 1:10 PM
Leerink Partners analyst Mani Foroohar raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $35.00 (from $29.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change